Teva Presents New Reslizumab Data at ERS International Congress 2015

By: via Benzinga
Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today presented results from a post hoc analysis of two pivotal ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.